Support and recognition for Sinnovial

The regional AMI MedTech programme has awarded a €20,000 grant to support the regulatory development of the SinnoTest currently being used in the PREDIRA clinical study.

In addition,  a €685,000 grant has been awarded by the French BPI Deeptech programme to Sinnovial in  support of the preclinical and clinical development of the next versions of SinnoTest in patients with rheumatoid arthritis and spondylarthritis.